Abbott gets CE Mark for Covid-19 IgG quant antibody test
Abbott has obtained CE Mark for its new lab-based quantitative Covid-19 IgG serology test, to measure the levels of IgG antibodies, produced against SARS-CoV-2 virus. Countries around the
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XAbbott has obtained CE Mark for its new lab-based quantitative Covid-19 IgG serology test, to measure the levels of IgG antibodies, produced against SARS-CoV-2 virus. Countries around the
Medical technology firm Genetesis has won the US Food and Drug Administration (FDA) Breakthrough Device Designation for its CardioFlux imaging technology. CardioFlux is an advanced magnetocardiograph (MCG), intended
Exero Medical, developer of a wireless system for early detection of anastomotic leaks (AL) following gastrointestinal (GI) surgery, today announced that it has been granted FDA Breakthrough Designation – a
Neovasc has completed the first three Neovasc Reducer™ (“Reducer”) implants in France. The implants are an important step for Neovasc as the Company continues to expand access for
Foldax has obtained the US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) to commence a clinical study of its Tria biopolymer mitral surgical heart valve in
3M has launched the new generation of its silicone adhesives, dubbed 3M Hi-Tack Silicone Adhesive Tapes, to help patients using wearable medical devices. The company said that acrylate
Spark Biomedical, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Roo System: a transcutaneous electrical nerve stimulator that aids
Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain
Psomagen, a CLIA-certified and CAP-accredited laboratory, has obtained the regulatory authorisation to provide Yale University SalivaDirect Covid-19 diagnostic test. The test developed by the Yale School of Public
Roche has announced its partnership with the French MedTech firm Diabeloop to advance the management of insulin pump therapy. Through the partnership, the companies aim to reduce the